Market Closed

TPST
Tempest Therapeutics
$ 0.3819
-0.29%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Tempest Therapeutics News

Latest Tempest Therapeutics Stock News & TPST Headlines

Tempest Reports Third Quarter 2026 Financial Results and Provides Business Update
a day ago | globenewswire.com
Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise
a month ago | globenewswire.com
Tempest signs related-party R&D pact, reshapes leadership
2 months ago | defenseworld.net
Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
2 months ago | benzinga.com
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
2 months ago | globenewswire.com
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
4 months ago | globenewswire.com
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
5 months ago | globenewswire.com
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
6 months ago | globenewswire.com
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
6 months ago | globenewswire.com
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
6 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

TPST
Tempest Therapeutics
$ 0.3819
-0.29%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago